Coherus BioSciences - 53 Year Dividend History | CHRS

Historical dividend payout and yield for Coherus BioSciences (CHRS) since 1971. The current TTM dividend payout for Coherus BioSciences (CHRS) as of May 24, 2024 is $0.00. The current dividend yield for Coherus BioSciences as of May 24, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.231B $0.257B
Coherus Biosciences, Inc. is a biologics platform company developing biosimilar therapeutics. Its clinical stage pipeline consists of CHS-0214 in two Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis; CHS-1420 that has completed a Phase I study to treat psoriasis or rheumatoid arthritis; and CHS-1701 which has completed a Phase I study for the treatment of breast cancer patients. Coherus Biosciences, Inc. is headquartered in Redwood City, California.
Stock Name Country Market Cap PE Ratio